Coronavirus vaccine: Moderna says its jab is 94.5 per cent effective and easier to store
Doctor preparing the coronavirus COVID-19 vaccine
Get our daily coronavirus email newsletter with all the news you need to know direct to your inbox
Sign upWhen you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.Thank you for subscribingWe have more newslettersShow meSee ourprivacy noticeInvalid Email
British scientists have hailed the "tremendously exciting" news that a US coronavirus vaccine may prevent 94.5% of people from getting Covid-19.
Interim data from the US firm Moderna suggests its vaccine is highly effective in preventing people getting ill and also works across all age groups, including the elderly.
The UK has not placed an order for the vaccine – which works in a similar way to Pfizer's – and it is unclear whether the British Government can get any stock.
But scientists said the news bodes well for other Covid-19 vaccines, with the one for Oxford University and UK pharmaceutical giant AstraZeneca due to report in the coming days or weeks.
Moderna intends to submit an application for an Emergency Use Authorisation with the US Food and Drug Administration shortly and will submit further data on the vaccine's effectiveness and safety.
(Image: Rafael Henrique/SOPA Images/REX/Shutterstock)
Coronavirus: Interactive tool shows your risk of Covid-19 at different events
Coronavirus has been circulating in Italy since September 2019, study claims
Best of all, the vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage infrastructure.
Moderna's vaccine is stable for up to six months at a temperature of minus 20 degrees Celsius (-4 F), about home freezer levels, when shipped and stored.
The company said it expects the vaccine to be stable when kept at standard refrigerator temperatures of 2 to 8 degrees Celsius for 30 days, up from an initial projection of 7 days.
Scientists have voiced optimism about Moderna Inc's vaccine candidate
(Image: AFP via Getty Images)
Coronavirus: Face masks could cause severe skin reactions, experts warn
The vaccine will be distributed in 10-dose vials and can be kept at room temperature for up to 12 hours after thawing.
By comparison, Pfizer's vaccine can be transported and stored for up to 6 months at minus 70 degrees Celsius (-94 F).
It can be stored at standard refrigerator temperatures for up to five days.
Moderna's vaccine will be distributed by the U.S. government's Operation Warp Speed program. U.S. health officials have said that at first they are most likely to distribute vaccines to healthcare workers, people who are in nursing homes, first responders and those with health conditions who are high-risk.
Click to play
Tap to play
The video will auto-play soon8Cancel
27% of Brits could refuse vaccine
Coronavirus vaccine latest
Coronavirus vaccine trial Phase 2 begins
Coronavirus vaccine trial extended
Most Americans will be inoculated in May or June, according to Dr. Anthony Fauci, the nation's top infectious disease expert.
Under Operation Warp Speed's distribution plan, the first group of shots will likely be distributed to and administered in closed settings, like hospitals and nursing homes.
After January, as supply increases, those shots will start to be available in pharmacies, doctors offices and clinics as well as mobile clinics, the plan shows.
Health officials have said it will be easier to use Moderna's vaccine in these settings than Pfizer's.
The stock market surged on the news, with the FTSE 100 soaring 60 points in the 10 minutes after the results of the trials went public.